reuters u food drug administration commissioner scott gottlieb consider potential successor recently depart health human service secretary tom price say tuesday believe could best serve trump administration current role
“ feel like want continue follow policy ’ put ’ think effective ” gottlieb tell reuters interview new york
decline say whether approach job white house
“ ’ go get private discussion might around ” say
gottlieb one several potential candidate top job hhs post vacate price last month follow uproar use private jet government business
name mention health policy expert include seema verma administrator center medicare medicaid service cm louisiana governor bobby jindal
gottlieb win mostly positive review since take fda commissioner may
introduce policy tackle country ’ biggest health challenge include opioid tobacco addiction rise prescription drug price
top post fda always difficult fill gottlieb note long stretch agency operate acting commissioner
gottlieb serve senior adviser fda commissioner mark mcclellan leave agency 2004 two year run cms move gottlieb say detrimental agency
“ ’ always challenge move fda commissioner ” say
“ continuity leadership important ” wideranging interview gottlieb say situation ground puerto rico 10 percent drug prescribe united state make “ bad ” shortage drug could emerge within little two three week
also say agency go clearly define regulation around cell therapy
law currently state cell extract patient ’ body minimally manipulate drug subject fda regulation
“ historically fda ’ vigorously enforce around line ’ implementing guideline ” say
time agency plan novel measure make easier small academic center apply fda product approval pool data generate similar work
“ academician work different academic site similar procedure stem cell follow protocol ’ go able pool data submit regulatory approval ” say